Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS)

Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS)

Recent randomized controlled multi-center trials JUPITER, CANTOS and COLCOT impressively demonstrated the effect of anti-inflammatory therapy on secondary prevention of cardiovascular events. These studies also rapidly re-vitalized the question of whether the C-reactive protein (CRP), the prototype...

Full description

Bibliographic Details
Main Authors: Myron Zaczkiewicz, Katharina Kostenzer, Matthias Graf, Benjamin Mayer, Oliver Zimmermann, Jan Torzewski
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Journal of Clinical Medicine
Subjects:
CRP
CRP synthesis inhibition
cardiovascular disease
Online Access:https://www.mdpi.com/2077-0383/11/7/1762

Internet

https://www.mdpi.com/2077-0383/11/7/1762

Similar Items